EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
07.01.25
/
50%
€8.89
Target price
07.01.26
€31.74
Performance (%)
62.08%
Price
16.12.25
€13.23
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for EyePoint Pharmaceuticals Inc. has seen massive gains of 62.08%. This prediction currently runs until 07.01.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 9.339% | 9.339% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $33.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat